BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15734007)

  • 1. Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up.
    Wang TJ; Chen MS; Shih YF; Hwu WL; Lai MY
    Am J Ophthalmol; 2005 Feb; 139(2):359-62. PubMed ID: 15734007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular changes in type I Gaucher's disease.
    Rosenthal G; Wollstein G; Klemperer I; Yagev R; Lfshitz T
    Ophthalmic Surg Lasers; 2000; 31(4):331-3. PubMed ID: 10928672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gaucher's disease. Substitutive enzymatic treatment in one case and a review of the literature].
    Rachid M; Harif M; Quessar A; Jabri L; Benchekroun S
    Tunis Med; 2005 Jan; 83(1):43-7. PubMed ID: 15881721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First long-term results of imiglucerase therapy of type 1 Gaucher disease.
    Niederau C; vom Dahl S; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological involvement in type 1 (adult) Gaucher's disease.
    McKeran RO; Bradbury P; Taylor D; Stern G
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):172-5. PubMed ID: 3981177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
    Sherer Y; Dulitzki M; Levy Y; Livneh A; Shoenfeld Y; Langevitz P
    Ann Hematol; 2002 Mar; 81(3):161-3. PubMed ID: 11904743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal involvement in Gaucher's disease].
    Gonzalez Rodriguez MJ; Pintado Conde H; Lopez Nieto C; Capdevila Puerta A; Torres Carrete JP
    J Fr Ophtalmol; 1992; 15(3):185-90. PubMed ID: 1640076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of Gaucher's disease associated with peripheral retinal ischemia].
    Jaime S; Dalmas MF
    J Fr Ophtalmol; 1989; 12(6-7):461-3. PubMed ID: 2636243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].
    Latre P; Giraldo P
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():39-42. PubMed ID: 22230124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
    Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
    Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher's disease associated with choroidal neovascularization.
    Giovannini A; Mariotti C; Scassellati-Sforzolini B; Amato G
    Retina; 2000; 20(6):679-81. PubMed ID: 11131429
    [No Abstract]   [Full Text] [Related]  

  • 19. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
    Banjar H
    Ann Trop Paediatr; 1998 Mar; 18(1):55-9. PubMed ID: 9692003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.